HC Wainwright & Co. Maintains Buy on Enlivex, Raises Price Target to $20

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Enlivex (NASDAQ:ENLV) with a Buy and raises the price target from $13 to $20.